Literature DB >> 21492370

Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia.

Paul Cathcart1, Declan G Murphy, Daniel Moon, Anthony J Costello, Mark Frydenberg.   

Abstract

OBJECTIVE: •  To systematically review the current literature concerning perioperative, functional and oncological outcomes reported after open and minimally invasive prostate cancer surgery specifically from institutions within Australasia.
MATERIALS AND METHODS: •  Four electronic databases were searched to identify studies reporting outcome after open and minimally invasive prostate cancer surgery. Studies were sought using the search term 'radical prostatectomy'. •  In all, 11,378 articles were retrieved. For the purpose of this review, data were only extracted from studies reporting Australasian experience. •  A total of 28 studies met final inclusion criteria.
RESULTS: •  Overall, the data are limited by the low methodological quality of available studies. •  Only two comparative studies evaluating open radical prostatectomy (ORP) and robotic-assisted laparoscopic RP (RALP) were identified, both non-randomized. •  The mean blood loss, catheterization time and hospital stay was shorter after RALP than with ORP. In contrast, mean operative procedure time was significantly longer for RALP. •  Overall adverse event rates were similar for the different surgical approaches although the rate of bladder neck stricture was significantly higher after open RP. •  Incorporation of patient outcomes achieved by surgeons still within their learning curve resulted in a trend towards higher positive surgical margin rates and lower continence scores after RALP. However, there was equivalence once the surgeons' learning curve was overcome. Given the limited follow-up for RALP and laparoscopic RP (14.7 and 6 months vs 43.8 months for ORP) and the lack of data concerning erectile function status, comparison of biochemical failure and potency was not possible.
CONCLUSIONS: •  Few comparative data are available from Australasia concerning open and minimally invasive prostate cancer surgery. •  While perioperative outcomes appear to favour minimally invasive approaches, further comparative assessment of functional and long-term oncological efficacy for the different surgical approaches is required to better define the role of minimally invasive approaches.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21492370     DOI: 10.1111/j.1464-410X.2011.10053.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  Learning curve assessment of robot-assisted radical prostatectomy compared with open-surgery controls from the premier perspective database.

Authors:  John W Davis; Usha S Kreaden; Jessica Gabbert; Raju Thomas
Journal:  J Endourol       Date:  2014-02-06       Impact factor: 2.942

Review 2.  Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence.

Authors:  Ahmed Saeed Goolam; Alfredo Harb-De la Rosa; Murugesan Manoharan
Journal:  Indian J Surg Oncol       Date:  2017-01-13

3.  Prospective comparison of the impact of robotic-assisted laparoscopic radical prostatectomy versus open radical prostatectomy on health-related quality of life and decision regret.

Authors:  B Joyce Davison; Andrew Matthew; Abbie M Gardner
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

4.  Effects of robotic-assisted laparoscopic prostatectomy on surgical pathology specimens.

Authors:  Heng Hong; Lin Mel; Jonathan Taylor; Qiang Wu; Hugh Reeves
Journal:  Diagn Pathol       Date:  2012-03-13       Impact factor: 2.644

5.  Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea.

Authors:  Ji Eun Yun; Na Rae Lee; Cheol Kwak; Koon Ho Rha; Seong Il Seo; Sung-Hoo Hong; Young Goo Lee; Dong Ah Park; Choung Soo Kim; Seon Heui Lee
Journal:  Prostate Int       Date:  2018-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.